Advanced Materials,
Journal Year:
2020,
Volume and Issue:
32(51)
Published: Oct. 5, 2020
Abstract
Exosomes
are
a
class
of
extracellular
vesicles
around
100
nm
in
diameter
that
secreted
by
most
cells
and
contain
various
bioactive
molecules
reflecting
their
cellular
origin
mediate
intercellular
communication.
Studies
these
exosomal
features
tumor
pathogenesis
have
led
to
the
development
therapeutic
diagnostic
approaches
using
exosomes
for
cancer
therapy.
many
advantages
conveying
agents
such
as
small
interfering
RNAs,
microRNAs,
membrane‐associated
proteins,
chemotherapeutic
compounds;
thus,
they
considered
prime
candidate
delivery
tool
treatment.
Since
also
provide
an
optimal
microenvironment
effective
function
immunomodulatory
factors,
harboring
been
bioengineered
immunotherapies
can
effectively
activate
each
stage
immunity
cycle
successfully
elicit
cancer‐specific
immunity.
This
review
discusses
treating
challenges
must
be
overcome
successful
clinical
development.
Cell & Bioscience,
Journal Year:
2019,
Volume and Issue:
9(1)
Published: Feb. 15, 2019
Exosomes
are
nano-sized
biovesicles
released
into
surrounding
body
fluids
upon
fusion
of
multivesicular
bodies
and
the
plasma
membrane.
They
were
shown
to
carry
cell-specific
cargos
proteins,
lipids,
genetic
materials,
can
be
selectively
taken
up
by
neighboring
or
distant
cells
far
from
their
release,
reprogramming
recipient
bioactive
compounds.
Therefore,
regulated
formation
exosomes,
specific
makeup
cargo,
cell-targeting
specificity
immense
biological
interest
considering
extremely
high
potential
exosomes
as
non-invasive
diagnostic
biomarkers,
well
therapeutic
nanocarriers.
In
present
review,
we
outline
discuss
recent
progress
in
elucidation
regulatory
mechanisms
exosome
biogenesis,
molecular
composition
technologies
used
research.
Furthermore,
focus
on
use
valuable
prognostic
biomarkers
for
cell-lineage
state-specific
contents,
possibilities
vehicles
drug
gene
delivery.
Exosome
research
is
now
its
infancy,
in-depth
understanding
subcellular
components
involved
will
bring
light
physiological
activities.
International Journal of Molecular Sciences,
Journal Year:
2017,
Volume and Issue:
18(9), P. 1852 - 1852
Published: Aug. 25, 2017
Earlier
research
primarily
attributed
the
effects
of
mesenchymal
stem
cell
(MSC)
therapies
to
their
capacity
for
local
engrafting
and
differentiating
into
multiple
tissue
types.
However,
recent
studies
have
revealed
that
implanted
cells
do
not
survive
long,
benefits
MSC
therapy
could
be
due
vast
array
bioactive
factors
they
produce,
which
play
an
important
role
in
regulation
key
biologic
processes.
Secretome
derivatives,
such
as
conditioned
media
or
exosomes,
may
present
considerable
advantages
over
manufacturing,
storage,
handling,
product
shelf
life
potential
a
ready-to-go
product.
Nevertheless,
regulatory
requirements
manufacturing
quality
control
will
necessary
establish
safety
efficacy
profile
these
products.
Among
MSCs,
human
uterine
cervical
(hUCESCs)
good
candidate
obtaining
secretome-derived
hUCESCs
are
obtained
by
Pap
smear,
is
less
invasive
painful
method
than
those
used
other
MSCs
(for
example,
from
bone
marrow
adipose
tissue).
Moreover,
easy
isolation
high
proliferative
rate,
it
possible
obtain
large
amounts
products
clinical
use.
International Journal of Nanomedicine,
Journal Year:
2020,
Volume and Issue:
Volume 15, P. 6917 - 6934
Published: Sept. 1, 2020
Exosomes
are
nano-sized
small
extracellular
vesicles
secreted
by
cells,
carrying
nucleic
acids,
proteins,
lipids
and
other
bioactive
substances
to
play
a
role
in
the
body's
physiological
pathological
processes.
Compared
synthetic
carriers
such
as
liposomes
nanoparticles,
endogeneity
heterogeneity
of
exosomes
give
them
extensive
unique
advantages
field
disease
diagnosis
treatment.
However,
storage
stability,
low
yield,
purity,
weak
targeting
limit
its
clinical
application.
For
this
reason,
further
exploration
is
needed
optimize
above
problems
facilitate
future
functional
studies
exosomes.
In
paper,
origin,
classification,
preparation
characterization,
stability
applications
exosome
delivery
system
summarized
discussed
searching
large
number
literatures.
Journal of Extracellular Vesicles,
Journal Year:
2016,
Volume and Issue:
5(1)
Published: Jan. 1, 2016
Extracellular
vesicles
(EVs),
including
exosomes
and
microvesicles
(MVs),
are
explored
for
use
in
diagnostics,
therapeutics
drug
delivery.
However,
little
is
known
about
the
relationship
of
protein
lipid
composition
EVs
their
source
cells.
Here,
we
report
high-resolution
lipidomic
proteomic
analyses
MVs
derived
by
differential
ultracentrifugation
from
3
different
cell
types:
U87
glioblastoma
cells,
Huh7
hepatocellular
carcinoma
cells
human
bone
marrow-derived
mesenchymal
stem
(MSCs).
We
identified
3,532
proteins
1,961
species
screen.
Exosomes
differed
several
areas:
(a)
The
patterns
were
more
likely
origin
than
MVs;
(b)
proteomes
similar
to
each
other
but
MSC
exosomes,
whereas
lipidomes
exosomes;
(c)
exhibited
extracellular
matrix,
heparin-binding,
receptors,
immune
response
adhesion
functions,
enriched
endoplasmic
reticulum,
proteasome
mitochondrial
proteins.
also
types
contents.
Enrichment
glycolipids
free
fatty
acids
characterized
enrichment
ceramides
sphingomyelins
MVs.
Furthermore,
specifically
cardiolipins;
sphingomyelins.
This
study
comprehensively
types.
Experimental & Molecular Medicine,
Journal Year:
2017,
Volume and Issue:
49(6), P. e346 - e346
Published: June 1, 2017
The
administration
of
mesenchymal
stem
cells
(MSCs)
as
a
therapy
for
liver
disease
holds
great
promise.
MSCs
can
differentiate
into
hepatocytes,
reduce
inflammation,
promote
hepatic
regeneration
and
secrete
protective
cytokines.
However,
the
risks
iatrogenic
tumor
formation,
cellular
rejection
infusional
toxicity
in
MSC
transplantation
remain
unresolved.
Accumulating
evidence
now
suggests
that
novel
cell-free
therapy,
MSC-secreted
exosomes,
might
constitute
compelling
alternative
because
their
advantages
over
corresponding
MSCs.
They
are
smaller
less
complex
than
parent
and,
thus,
easier
to
produce
store,
they
devoid
viable
cells,
present
no
risk
formation.
Moreover,
immunogenic
lower
content
membrane-bound
proteins.
This
paper
reviews
biogenesis
exosomes
physiological
functions,
highlights
specific
biochemical
potential
MSC-derived
restoring
tissue
homeostasis.
In
addition,
we
summarize
recent
advances
role
various
diseases,
including
fibrosis,
acute
injury
hepatocellular
carcinoma.
also
discusses
challenges
strategies
use
exosome-based
therapies
future.
Tiny
vesicles
secreted
by
adult
could
help
treat
fibrosis
cancer.
Mesenchymal
(MSCs),
which
be
derived
from
bone
marrow,
cord
blood
or
other
sources,
have
ability
but
form
tumors
rejected
immune
system,
raising
safety
concerns.
review
article,
Yanning
Liu
colleagues
Zhejiang
University
Hangzhou,
China,
discuss
how
administering
small
known
released
offers
safer
assisting
following
disease.
researchers
data
mouse
models
showing
therapeutic
properties
exosomes.
further
steps
needed,
such
better
standardization,
allow
human
clinical
trials
proceed.
Pharmaceutics,
Journal Year:
2018,
Volume and Issue:
10(4), P. 218 - 218
Published: Nov. 6, 2018
The
similarities
between
exosomes
and
liposomes,
together
with
the
high
organotropism
of
several
types
exosomes,
have
recently
prompted
development
engineered-exosomes
or
exosome-mimetics,
which
may
be
artificial
(liposomal)
cell-derived
vesicles,
as
advanced
platforms
for
targeted
drug
delivery.
Here,
we
provide
current
state-of-the-art
using
exosome
exosome-inspired
systems
We
review
various
approaches
investigated
shortcomings
each
approach.
Finally
challenges
been
identified
to
date
in
this
field
are
summarized.